Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Other Non-Current Assets of $100.2 million in Q1 2026, up 2983.23% quarter-over-quarter from $3.2 million in Q4 2025, and up 493.17% on a YoY basis from $16.9 million in Q1 2025.
Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $100.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 493.17% year-over-year to $100.2 million; the TTM figure through Mar 2026 stood at $100.2 million (up 493.17% YoY), while the FY2025 annual figure was $99.5 million, up 1267.18% from the prior year.
- Other Non-Current Assets was $100.2 million for Q1 2026 at Phibro Animal Health, up from $3.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $107.3 million in Q4 2024 to a low of $615000.0 in Q3 2025.
- Historically, Other Non-Current Assets has averaged $27.5 million across 5 years, with a median of $6.6 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets sank 98.48% in 2023, then surged 4421.54% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $5.9 million in 2022, then sank by 60.01% to $2.4 million in 2023, then soared by 4421.54% to $107.3 million in 2024, then plunged by 96.97% to $3.2 million in 2025, then jumped by 2983.23% to $100.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $100.2 million (Q1 2026), $3.2 million (Q4 2025), and $615000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 100.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.21 Mn |
| Dec 31, 2025 | 3.25 Mn |
| Sep 30, 2025 | 615,000.00 |
| Jun 30, 2025 | 99.49 Mn |
| Mar 31, 2025 | 16.89 Mn |
| Dec 31, 2024 | 107.25 Mn |
| Sep 30, 2024 | 8.84 Mn |
| Jun 30, 2024 | 7.28 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 6.16 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 84.56 Mn |
| Jun 30, 2022 | 8.70 Mn |
| Mar 31, 2022 | 6.29 Mn |
| Dec 31, 2021 | 75.11 Mn |
| Sep 30, 2021 | 71.78 Mn |
| Jun 30, 2021 | 5.66 Mn |